{
    "2018-11-21": [
        [
            {
                "time": "",
                "original_text": "医疗保健：仿制药格局变革 荐9股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "仿制药",
                        "格局变革"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健",
                        "仿制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "欧普康视：不改主业增长势头 买入评级",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "主业增长",
                        "买入评级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "下注570万元设立合资公司，欧普康视布局基因检测为哪般？",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "基因检测",
                        "合资公司"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基因检测",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2019年度策略:估值修复,深挖个股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "估值修复",
                        "年度策略"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}